Macular degeneration trials in Singapore

In Singapore 6 Also abroad 220

6 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 3Active, not recruiting
Single Intravitreal (IVT) Injection of 4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
Where
Singapore
Age
50 years and over
People
480 worldwide
Run by
4D Molecular Therapeutics
See details and how to joinNCT07064759
No phaseEnrolling by invitation
User-centric Study of Patients' Receptiveness Towards the Web-based Automated Vision Impairment Gaze-tracking Analysis Systems
Where
Singapore
Age
55 years to 99 years
People
30
Run by
Tan Tock Seng Hospital
See details and how to joinNCT07338513
No phaseTaking people
Identification of Molecular Signals in Vitreous Humor Associated With Suboptimal Response to Vascular Endothelial Growth Factor (VEGF) Inhibition in Neovascular Age-related Macular Degeneration (nAMD) Within a Clinical Trial Setting
Where
Singapore
Age
50 years and over
People
117
Run by
Singapore National Eye Centre
See details and how to joinNCT07249216
No phaseTaking people
AVIGA3 (Cohort 2.0)
Where
Singapore
Age
50 years to 99 years
People
60
Run by
Tan Tock Seng Hospital
See details and how to joinNCT07255859
No phaseTaking people
Predicting Risk of Progression of Early to Late AMD in the Aging Eye Through Imaging and Multimodal Evaluation
Where
Singapore
Age
55 years and over
People
1,500
Run by
Singapore National Eye Centre
See details and how to joinNCT07653269
Phase 1/2Taking people
A Study of PRL3-zumab in Neovascular Age-related Macular Degeneration (nAMD)
Where
Singapore
Age
18 years and over
People
15
Run by
Intra-IMMUSG Pte Ltd
See details and how to joinNCT07547228